Restricted accessResearch articleFirst published online 2019-4
Gas Chromatography–Mass Spectrometry (GC–MS) and Gas Chromatography–Infrared (GC–IR) Analyses of the Chloro-1- n -pentyl-3-(1-naphthoyl)-Indoles: Regioisomeric Cannabinoids
The analytical differentiation of the indole ring regioisomeric chloro-1-n-pentyl-3-(1-naphthoyl)-indoles is described in this report. The regioisomeric chloroindole precursor compounds, N-n-pentyl chloroindole synthetic intermediates, and the target chloro-substituted naphthoylindoles showed the equivalent gas chromatographic elution order based on the position of chlorine substitution on the indole ring. The regioisomeric chloro-1-n-pentyl-3-(1-naphthoyl)-indoles yield electron ionization mass spectra having equivalent major fragments resulting from cleavage of the groups attached to the central indole nucleus. Fragment ions occur at m/z 127 and 155 for the naphthyl and naphthoyl cations common to all indoles having the naphthoyl group substituted at the indole-3 position. Fragments resulting from the loss of the naphthoyl and/or n-pentyl groups from the molecular radical cation yield the cations at m/z 318, 304, 248, and 178. The characteristic (M–17)+ fragment ion at m/z 358 resulting from the loss of OH radical is significant in the mass spectra of all these compounds with 1-naphthoyl groups substituted at the indole-3 position. The vapor phase infrared spectra provide a number of characteristic absorption bands to identify the individual isomers.
BaumannM.H.SolisE.JrWattersonL.R.MarusichJ.A.et al.“Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines”. J. Neurosci. 2014. 34(46): 15150–15158.
3.
LewinA.H.SeltzmanH.H.CarrollF.I.MascarellaS.W.et al.“Emergence and Properties of Spice and Bath Salts: A Medicinal Chemistry Prospective”. Life Sci. 2014. 97(1): 9–19.
4.
CarrollF.I.LewinA.H.MascarellaS.W.SeltzmanH.H.et al.“Designer Drugs: A Medicinal Chemistry Perspective”. Ann. N. Y. Acad. Sci. 2012. 1248(1): 18–38.
5.
BanisterS.D.StuartJ.ConroyT.LongworthM.et al.“Structure-Activity Relationships of Synthetic Cannabinoid Designer Drug RCS-4 and its Regioisomers and C4 Homologues”. Forensic Toxicol. 2015. 33(2): 355–366.
6.
ParkY.LeeC.LeeH.PyoJ.et al.“Identification of a new synthetic cannabinoid in a herbal mixture: 1-butyl-3-(2-methoxybenzoyl)indole”. Forensic Toxicol. 2013. 31(2): 187–196.
7.
Drug Enforcement Administration (DEA). “Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids into Schedule I”. U.S. Department of Justice. Federal Register. 2011. 76(40): 11075–11078. https://www.gpo.gov/fdsys/pkg/FR-2011-03-01/html/2011-4428.htm [accessed Oct 3 2018].
8.
A.T. Shulgin, A. Shulgin. PiHKAL: A Chemical Love Story. Berkeley, CA: Transform Press, 1991.
9.
FantegrossiW.E.CiulloJ.R.WakabayashiK.T.De La GarzaR.et al.“A Comparison of the Physiological, Behavioral, Neurochemical and Microglial Effects of Methamphetamine and 3,4-Methylenedioxymethamphetamine in the Mouse”. Neuroscience. 2008. 151(2): 533–543.
10.
DeRuiterJ.ClarkC.R.NoggleF.T..“GC–MS and HPLC Analysis of Bromination Products of the Regioisomeric Dimethoxyphenethylamines: Differentiation of Nexus from Five Positional Isomers”. J. Chromatogr. Sci. 1998. 36(1): 23–28.
11.
European Monitoring System for Drugs and Drug Addition (EMCDDA). European Drug Report 2018. http://www.emcdda.europa.eu/edr2018_en [accessed Oct 3 2018].
12.
LinJ.C.JanR.K.KyddR.R.RussellB.R..“Subjective Effects in Humans Following Administration of Party Pill Drugs BZP and TFMPP Alone and in Combination”. Drug Test. Anal. 2011. 3(9): 582–585.
13.
YaroshH.L.KatzE.B.CoopA.FantegrossiW.E..“MDMA-Like Behavioral Effects of N-Substituted Piperazines in the Mouse”. Pharmacol. Biochem. Behav. 2007. 88(1): 18–27.
14.
YeapC.W.BianC.K.AbdullahA.F.L..“A Review on Benzylpiperazine and Trifluoromethylphenypiperazine: Origins, Effects, Prevalence and Legal Status”. Health Environ. J. 2010. 1(2): 38–50.
15.
R. Heim. “Synthesis and Pharmacology of Potent 5-HT2A Receptor Agonists with N-2-Methoxybenzyl Partial Structure”. [Ph.D. Thesis]. Berlin, Germany: Free University, 2003.
16.
PoklisJ.L.RasoS.A.AlfordK.N.PioklisA.et al.“Analysis of 25I-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxy) Methyl]Ethanamine Derivatives on Blotter Paper”. J. Anal. Toxicol. 2015. 39(8): 617–623.
17.
PoklisJ.L.DemposeyS.K.LiuK.RitterJ.K.et al.“Identification of Metabolite Biomarkers of the Designer Hallucinogen 25I-NBOMe in Mouse Hepatic Microsomal Preparations and Human Urine Samples Associated with Clinical Intoxication”. J. Anal. Toxicol. 2015. 39(8): 607–616.
18.
ShanksK.G.SozioT.BehonickG.S..“Fatal Intoxications with 25B-NBOMe, 25I-NBOMe in Indiana During 2014”. J. Anal. Toxicol. 2015. 39(8): 602–606.
19.
HuffmanJ.W.ZenginG.WuM.J.LuJ.et al.“Structure–Activity Relationships for 1-Alkyl-3-(1-naphthoyl) Indoles at the Cannabinoid CB1 and CB2 Receptors: Steric and Electronic Effects of Naphthoyl Substituents. New Highly Selective CB2 Receptor Agonists”. Bioorganic Med. Chem. 2005. 13(1): 89–112.
20.
ShevyrinV.MelkozerovV.NeveroA.EltsonO.et al.“Identification and Analytical Properties of New Synthetic Cannabimimetics Bearing 2,2,3,3-Tetramethylcyclopropanecarbonyl Moiety”. Forensic Sci. Int. 2013. 226(1–3): 62–73.
21.
AungM.M.GriffinG.HuffmanJ.W.WuM.J.et al.“Influence of the N-1 Alkyl Chain Length of Cannabimimetic Indoles upon CB1 and CB2 Receptor Binding”. Drug Alcohol Depend. 2000. 60(2): 133–140.
22.
UchiyamaN.MatsudaS.KawamuraM.Kikura-HanajiriR.et al.“Two New-Type Cannabimimetic Quinolinyl Carboxylates, QUPIC and QUCHIC, Two New Cannabimimetic Carboxamide Derivatives, ADB-FUBINACA and ADBICA, and Five Synthetic Cannabinoids Detected with a Thiophene Derivative a-PVT and an Opioid Receptor Agonist AH-7921 Identified in Illegal Products”. Forensic Toxicol. 2013. 31(2): 223–240.
23.
BelalT.S.Thaxton-WeissenfluhA.DeRuiterJ.SmithF.et al.“Differentiation of Methylated Indole Ring Regioisomers of JWH-007: GC-MS and GC-IR Studies”. Forensic Chem. 2018. 7: 1–9.
24.
HuffmanJ.W.LuJ.HyndG.WileyJ.L.et al.“A Pyridine Analogue of Traditional Cannabinoids. A New Class of Selective Ligands for the CB2 Receptor”. Bioorganic Med. Chem. 2001. 9(11): 2863–2870.
25.
AmatoJ.IaccarinoN.PaganoB.CompagnoneV.et al.“NMR Assignment of N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide Seized as Herbal Incense for the First Time in Italy”. J. Forensic Sci. Criminol. 2014. 2(1): 1–6.
26.
AtwoodB.K.HuffmanJ.StraikerA.MackieK..“JWH018, a Common Constituent of ‘Spice’ Herbal Blends, is a Potent and Efficacious Cannabinoid CB1 Receptor Agonist”. Br. J. Pharmacol. 2010. 160(3): 585–593.
27.
HarrisD.N.HokansonS.MillerV.JacksonG.P..“Fragmentation Differences in the EI Spectra of Three Synthetic Cannabinoid Positional Isomers: JWH-250, JWH-302, and JWH-201”. Int. J. Mass Spectrom. 2014. 368: 23–29.
28.
NakajimaJ.TakahashiM.NonakaR.SetoT.et al.“Identification and Quantitation of a Benzoylindole (2-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone and a Naphthoylindole 1-(5-Fluoropentyl-1H-indol-3-yl)-(naphthalene-1-yl)methanone (AM-2201) Found in Illegal Products Obtained via the Internet and their Cannabimimetic Effects Evaluated by in vitro [35S] GTPcS Binding Assays”. Forensic Toxicol. 2011. 29(2): 132–141.
29.
KavanaghP.GrigoryevA.MelnikA.SimonovA..“The Identification of the Urinary Metabolites of 3-(4-methoxybenzoyl)-1-pentylindole (RCS-4), a Novel Cannabimimetic, by Gas Chromatography–Mass Spectrometry”. J. Anal. Toxicol. 2012. 36(5): 303–311.
30.
ThaxtonA.BelalT.S.SmithF.DeRuiterJ.et al.“GC-MS Studies on the Six Naphthoyl-Substituted 1-Pentyl-Indoles: JWH-018 and Five Regioisomeric Equivalents”. Forensic Sci. Int. 2015. 252: 107–113.
31.
Thaxton-WeissenfluhA.AlsegianiA.S.AbiedallaY.DeRuiterJ.et al.“Analytical Studies on the 2-Naphthoyl Substituted-1-n-Pentylindoles: Regioisomeric Synthetic Cannabinoids”. J. Chromatogr. B. 2018. 1077–1078: 77–84.
32.
SmithL.W.Thaxton-WeissenfluhA.AbiedallaY.DeRuiterJ.et al.“Correlation of Vapor Phase Infrared Spectra and Regioisomeric Structure in Synthetic Cannabinoids”. Spectrochim. Acta, Part A. 2018. 196: 375–384.
33.
DeRuiterJ.Abdel-HayK.M.SmithF.T.ClarkC.R..“Analytical Differentiation of 1-Alkyl-3-acylindoles and 1-Acyl-3-alkylindoles: Isomeric Synthetic Cannabinoids”. Anal. Chem. 2014. 86(8): 3801–3808.
34.
ThaxtonA.BelalT.S.SmithF.DeRuiterJ.et al.“Mass Spectral Studies on 1-n-pentyl-3-(1-Naphthoyl)-Indole (JWH-018), Three Deuterium Labeled Analogues and the Inverse Isomer 1-Naphthoyl-3-n-pentylindole”. Rapid Commun. Mass Spectrom. 2015. 29(9): 871–877.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
